Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

Research grant holder first to be graded at UFS in NRF’s Thuthuka Programme
2007-11-17

 

In the picture, from the left are: Ms Gudrun Schirge (National Research Foundation), Mr Nico Benson (Directorate Research Development at the UFS), Prof Heidi Hudson (Department of Political Science at the UFS) and Dr Annelize Venter (Co-ordinator of the Thuthuka Programme at the UFS)
Photo: Mangaliso Radebe

 

Research grant holder first to be graded at UFS in NRF’s Thuthuka Programme

Prof. Heidi Hudson, Departmental Chairperson at the University of the Free State's (UFS) Department of Political Science, recently received a C1 grading from the National Research Foundation (NRF).

With this grading she became the first researcher and grant holder in the Thuthuka Programme for young researchers at the UFS to be graded by the NRF.

“The Thuthuka Programme is a capacity building initiative from the NRF which prepares young researchers for grading and provides them with a good grounding for research,” said Dr Annelize Venter, researcher at the UFS Research Development Directorate and co-ordinator of the Thuthuka Programme.

According to Dr Venter, the UFS currently has 44 researchers who receive funding from the Thuthuka Programme for their postgraduate studies. The results of possible entrants to the programme in 2008 are awaited.

”The UFS also received ten researchers additional to the current 69 who have a valid evaluation status. The results of an additional 11 applications are also awaited. Some of these are first applications,” said Dr Venter.

Over and above the grant holders in the Thuthuka Programme, any researcher can apply to be evaluated by the NRF’s Evaluation Centre. The evaluation status of a researcher serves as the norm determinator and the quality of research at a university is measured according to this.

Ms Gudrun Schirge from the NRF presented a workshop today at the UFS to researchers who wanted to apply for grading and evaluation.
Researchers who wished to apply for the re-evaluation of their current evaluation status also attended the workshop.

Ms Schirge was one of the founders of the evaluation system and has been a manager at the Evaluation Centre for the past 20 years. She will be retiring this year and will be involved with the centre on a part-time basis.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
16 November 2007
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept